Trulieve Cannabis Corp.
TRLV | NYSE
$10.28
-$0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM ET
$10.40
+$0.12 (+1.17%)
Pre-market:
Nov 2, 2026, 7:03 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Revenue | 1.14B | 1.17B | 883.42M | 590.27M | 302.09M |
Cost of Revenue | 461.65M | 472.15M | 355.47M | 237.49M | 119.16M |
Gross Profit | 677.39M | 698.03M | 527.95M | 352.78M | 182.93M |
Operating Income | -274.26M | 148.65M | 113.2M | 93.77M | 52.38M |
Interest Income | 13.56M | 14.14M | 11.45M | 8.03M | 3.64M |
Pretax Income | -325.93M | 96.37M | 71.15M | 68.21M | 38.9M |
Net Income | -473.39M | -81.11M | -83.51M | -40.62M | -13.78M |
Selling & General & Admin | 431.99M | 431.34M | 326.44M | 200.14M | 101.12M |
Research & Development | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 519.67M | 118.05M | 88.31M | 58.88M | 29.43M |
Operating Expenses | 951.65M | 549.38M | 414.75M | 259.02M | 130.54M |
Interest Expense | 56.85M | 60.48M | 47.16M | 32.48M | 16.39M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.41B | 1.02B | 770.22M | 496.51M | 249.7M |
Income Tax Expense | 144.75M | 177.5M | 155.65M | 107.76M | 54.72M |
Shares Outstanding (Basic) | 192.71M | 192.54M | 191.7M | 191.2M | 191.2M |
Shares Outstanding (Diluted) | 192.71M | 197.76M | 191.7M | 191.2M | 191.2M |
EPS (Basic) | -2.45 | -0.42 | -0.43 | -0.21 | -0.07 |
EPS (Diluted) | -2.45 | -0.42 | -0.43 | -0.21 | -0.07 |
EBITDA | -138.29M | 330.8M | 248.52M | 187.24M | 98.45M |
EBIT | -269.09M | 156.85M | 118.3M | 100.68M | 55.3M |
Depreciation & Amortization | 130.8M | 173.95M | 130.22M | 86.55M | 43.15M |
Add to Watchlist
Select watchlists to add or remove TRLV